top of page
< Back

Flunisolide


Mechanism of action:

Flunisolide is an inhaled corticosteroid. After inhalation into the respiratory tract, flunisolide enters cells and binds to the glucocorticoid receptor. The drug-receptor complex then translocates into the nucleus, where it increases the expression of anti-inflammatory genes such as annexin A1 and suppresses inflammatory transcription factors such as NF-κB and AP-1.

Reference(s):

1. Hochhaus G et al. (1990). Binding affinities of rimexolone (ORG 6216), flunisolide and their putative metabolites for the glucocorticoid receptor of human synovial tissue. Agents Actions. 


2. Johnson M et al. (1998). Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol. 


3. Valotis A et al. (2004). Significant receptor affinities of metabolites and a degradation product of mometasone furoate. Respir Res.

bottom of page